A Study on the Effects in Healthy People of a New Drug Called PDI204 for Treating COVID-19
A Study on the Effects in Healthy People of a New Drug Called PDI204 for Treating COVID-19
Active, not recruiting · NCT06965751 · Registry updated 2026-05-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study on the Effects in Healthy People of a New Drug Called PDI204 for Treating COVID-19 | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Phase 1 | 2026-05-05 | NCT06965751 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Nucleus Network Ltd | 3 |
| Syneos Heath | 1 |
| University of Melbourne | 71 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Nucleus Network | Melbourne | Australia | 13 |